 DOLONEUTIN
|
Géminis Farmacéutica
|
| pregabalina |
Antiepiléptico |
| 150 mg cáps.x 30 | $41.599,00 | (25/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $20.004,24 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.989,52 AF $13.609,48 |
|
|
|
|
| 25 mg cáps.x 30 | $8.782,20 | (17/12/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $4.246,66 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.262,08 AF $1.520,12 |
|
|
|
|
| 300 mg cáps.x 30 | $59.350,00 | (25/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $20.711,31 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $41.488,21 AF $17.861,79 |
|
|
|
|
| 50 mg cáps.x 30 | $22.140,00 | (17/12/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $8.537,23 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.449,24 AF $6.690,76 |
|
|
|
|
| 75 mg cáps.x 15 | $14.862,50 | (17/12/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $5.619,97 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $10.600,45 AF $4.262,05 |
|
|
|
|
| 75 mg cáps.x 30 | $25.290,65 | (17/12/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $12.627,50 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.932,47 AF $5.358,18 |
|
|
|
|
| |
